跳至主要内容
临床试验/NCT01360502
NCT01360502已完成不适用

Safety of Capsule Endoscopy Using Human Body Communication in Patients With Cardiac Pacemakers and Implantable Cardiac Defibrillators

Yonsei University1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
1

研究概览

简要总结

This is a prospective study designed to assess safety and potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.

详细描述

MiroCam (IntroMedic, Ltd, Seoul, Korea) is a small bowel capsule endoscope using human body communication for data transmission. There is a concern of potential interactions between cardiac devices and capsule endoscope. This clinical study was designed to evaluate the potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 20 years or older
  • cardiac pacemaker or implantable cardiac defibrillator
  • gastrointestinal disease

排除标准

  • previous GI perforation or obstruction history
  • known or suspected GI stricture
  • marked GI dysmotility
  • uncompensated heart failure (EF ≤30% or Killip's classification class ≥ III)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验